Financial News
Tilray stock soars 10% after company tapped to provide medical cannabis in French study
January 26, 2021 at 11:18 AM EST
Tilray's products will treat patients with neuropathic pain, epilepsy and multiple sclerosis who aren't getting relief from existing treatments.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
